Get started
DARYA-VARIA LABORATORIADD

DARYA-VARIA LABORATORIA

1,695IDRD
+5+0.30%
At close at Jun 5, 09:54 GMT
IDR
No trades
See on Supercharts
Overview
Financials
Discussions Technicals Seasonals

DVLA fundamentals

Key facts

Market capitalization‪1.89 T‬IDR
Dividend yield (indicated)6.39%
Price to earnings Ratio (TTM)11.30
Basic EPS (TTM)149.58IDR
Founded1976
Employees (FY)‪1.27 K‬
CEOIan Martin Wibawa Kloer
Websitedarya-varia.com
About

PT Darya-Varia Laboratoria Tbk engages in the manufacture and trade of pharmaceutical products and cosmetics. It operates through the following segments: Prescription Drugs, Consumer Health Products, and Export and Toll Manufacturing. The company was founded on February 5, 1976 and is headquartered in Jakarta, Indonesia.

Ownership
‪‪1.12 B‬‬
Closely held shares
‪‪1.03 B‬‬ (92.13%)
Free Float shares
‪‪88.20 M‬‬ (7.87%)
Closely held shares
‪‪1.03 B‬‬ (92.13%)
Free Float shares
‪‪88.20 M‬‬ (7.87%)
Capital structure
Market cap
‪‪1.89 T‬‬
Debt
‪‪933.43 M‬‬
Minority interest
‪‪1.00 M‬‬
Cash & equivalents
‪‪398.87 B‬‬
Enterprise value
‪‪1.49 T‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪1.89 T‬‬
Price to earning ratio (P/E)
11.30x
Price to sales ratio (P/S)
0.90x
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
11.30x
Price to sales ratio (P/S)
0.90x
Valuation ratios
‪0.00‬
‪0.25‬
‪0.50‬
‪0.75‬
‪1.00‬
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪0.00‬
‪3.00‬
‪6.00‬
‪9.00‬
‪12.00‬
P/E
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪1.5%‬
‪5.0%‬
‪8.5%‬
‪12.0%‬
‪15.5%‬
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪0.00‬
‪‪150.00 B‬‬
‪‪300.00 B‬‬
‪‪450.00 B‬‬
‪‪600.00 B‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪0.00‬
‪‪150.00 B‬‬
‪‪300.00 B‬‬
‪‪450.00 B‬‬
‪‪600.00 B‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪0.00‬
‪‪150.00 B‬‬
‪‪300.00 B‬‬
‪‪450.00 B‬‬
‪‪600.00 B‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2024
Consumer Health Products
Prescription Drugs
Export & Toll Manufacturing
Services
By country
Period: 2024
Indonesia
International

Dividends

Dividend yield, history and sustainability

Dividend summary
0.00%
Payout ratio (TTM)
Dividend yield TTM
6.39%
Last payment
43.00
Last ex-date
Nov 1, 2024
Last pay date
Nov 21, 2024
Dividend history
‪4.0%‬
‪4.7%‬
‪5.4%‬
‪6.1%‬
‪6.8%‬
2020
2021
2022
2023
2024
‪0.00‬
‪30.00‬
‪60.00‬
‪90.00‬
‪120.00‬
Dividends per share (FY)
Dividend yield (FY) %

Financial health

Financial position and solvency of the company

Debt level and coverage
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪‪−150.00 B‬‬
‪0.00‬
‪‪150.00 B‬‬
‪‪300.00 B‬‬
‪‪450.00 B‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
‪0.00‬
‪‪500.00 B‬‬
‪‪1.00 T‬‬
‪‪1.50 T‬‬
‪‪2.00 T‬‬
Assets
Liabilities